000 01177 a2200349 4500
005 20250513112919.0
264 0 _c19970529
008 199705s 0 0 eng d
022 _a0009-9120
024 7 _a10.1016/s0009-9120(96)00133-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYasasever, V
245 0 0 _aUtility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: special emphasis on "spiking" phenomena.
_h[electronic resource]
260 _bClinical biochemistry
_cFeb 1997
300 _a53-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aBone Neoplasms
_xblood
650 0 4 _aBreast Neoplasms
_xblood
650 0 4 _aCarcinoembryonic Antigen
_xblood
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aMucin-1
_xblood
700 1 _aDinçer, M
700 1 _aCamlica, H
700 1 _aKaraloğlu, D
700 1 _aDalay, N
773 0 _tClinical biochemistry
_gvol. 30
_gno. 1
_gp. 53-6
856 4 0 _uhttps://doi.org/10.1016/s0009-9120(96)00133-6
_zAvailable from publisher's website
999 _c9044232
_d9044232